DocGo’s (DCGO) “Buy” Rating Reiterated at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday, Benzinga reports.

Several other equities analysts also recently issued reports on the stock. Canaccord Genuity Group restated a “hold” rating and issued a $1.00 price objective on shares of DocGo in a research note on Tuesday, August 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $2.38.

DocGo Trading Up 8.6%

Shares of DCGO stock traded up $0.03 on Wednesday, reaching $0.40. 652,104 shares of the stock were exchanged, compared to its average volume of 884,416. The business’s 50 day moving average price is $0.48 and its 200 day moving average price is $0.56. The company has a market capitalization of $39.55 million, a price-to-earnings ratio of -0.20 and a beta of 0.94. DocGo has a twelve month low of $0.31 and a twelve month high of $1.65.

DocGo (NASDAQ:DCGO) last issued its earnings results on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%.The firm had revenue of $73.42 million for the quarter, compared to analyst estimates of $75.35 million. Equities research analysts forecast that DocGo will post -0.22 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of DCGO. Diversify Advisory Services LLC purchased a new position in shares of DocGo during the 2nd quarter worth approximately $53,000. Empowered Funds LLC purchased a new position in shares of DocGo during the 2nd quarter worth approximately $79,000. Ieq Capital LLC purchased a new position in shares of DocGo during the 2nd quarter worth approximately $126,000. Marquette Asset Management LLC purchased a new position in shares of DocGo during the 2nd quarter worth approximately $175,000. Finally, GSA Capital Partners LLP purchased a new position in shares of DocGo during the 2nd quarter worth approximately $517,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

About DocGo

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.